Loading clinical trials...
Loading clinical trials...
Hypophosphatasia (HPP) is a genetic disorder caused by mutation in the tissue-non-specific alkaline phosphatase gene (TNSALP). It causes impaired bone mineralisation, fractures, tooth loss, muscle wea...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Sheffield Teaching Hospitals NHS Foundation Trust
NCT07390240 · Hypophosphatasia
NCT05234567 · Hypophosphatasia
NCT07179640 · Hypophosphatasia (HPP)
NCT06079372 · Hypophosphatasia
NCT06015750 · Hypophosphatasia
Academic Unit of Bone Metabolism (Sheffield)
Sheffield, South Yorks
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions